SOPHiA GENETICS SA (SOPH)

NASDAQ: SOPH · IEX Real-Time Price · USD
2.12
+0.09 (4.19%)
Nov 29, 2022 3:30 PM EDT - Market open
4.19%
Market Cap 130.35M
Revenue (ttm) 45.11M
Net Income (ttm) -94.85M
Shares Out 64.15M
EPS (ttm) -1.46
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 37,317
Open 2.07
Previous Close 2.03
Day's Range 2.04 - 2.21
52-Week Range 1.69 - 15.83
Beta n/a
Analysts Buy
Price Target 13.26 (+527.0%)
Earnings Date Nov 8, 2022

About SOPH

SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland. [Read more]

Industry Health Information Services
IPO Date Jul 23, 2021
Employees 518
Stock Exchange NASDAQ
Ticker Symbol SOPH
Full Company Profile

Financial Performance

In 2021, SOPH's revenue was $40.45 million, an increase of 42.43% compared to the previous year's $28.40 million. Losses were -$73.68 million, 87.3% more than in 2020.

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for SOPH stock is "Buy." The 12-month stock price forecast is 13.26, which is an increase of 526.95% from the latest price.

Price Target
$13.26
(526.95% upside)
Analyst Consensus: Buy
Stock Forecasts

News

SOPHiA GENETICS SA (SOPH) Reports Q3 Loss, Tops Revenue Estimates

SOPHiA GENETICS SA (SOPH) delivered earnings and revenue surprises of -5.88% and 0.04%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

3 weeks ago - Zacks Investment Research

SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2022

Sustainable growth momentum evident despite foreign exchange headwinds Sustainable growth momentum evident despite foreign exchange headwinds

3 weeks ago - GlobeNewsWire

SOPHiA GENETICS to Participate in Upcoming November Investor Conferences

BOSTON and LAUSANNE, Switzerland, Nov. 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today the company will be partic...

3 weeks ago - GlobeNewsWire

SOPHiA GENETICS Partners with Microsoft to Accelerate Multimodal Health Data Analysis

The agreement is to expand and reinforce data-driven medicine through the SOPHiA DDM™ health data analysis platform available with Microsoft Azure GENEVA , Nov. 1, 2022 /PRNewswire/ -- SOPHiA GENETICS™ ...

4 weeks ago - PRNewsWire

SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2022 on November 8, 2022

BOSTON and GENEVA, Switzerland, Oct. 06, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced it will release its financial r...

1 month ago - GlobeNewsWire

SOPHiA GENETICS Unveils Strategy to Drive Health Care Innovations at Inaugural Investor Day Event

Highlights include: a memorandum of understanding with Memorial Sloan Kettering Cancer Center and a novel new partnership with Boundless Bio, a next-generation precision oncology company  SOPHiA GENETIC...

2 months ago - PRNewsWire

SOPHiA GENETICS to Highlight Innovations and Announcements at Investor Day on September 20, 2022

BOSTON and GENEVA, Switzerland, Sept. 20, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, will host its first-ever Investor Day TODAY in...

2 months ago - GlobeNewsWire

SOPHiA GENETICS to Participate in Fireside Chat at 20th Annual Morgan Stanley Global Healthcare Conference

BOSTON and LAUSANNE, Switzerland, Sept. 02, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today Chief Executive Officer, ...

2 months ago - GlobeNewsWire

SOPHiA GENETICS SA (SOPH) Reports Q2 Loss, Lags Revenue Estimates

SOPHiA GENETICS SA (SOPH) delivered earnings and revenue surprises of 0% and 0.88%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2022

Steady Operational Performance Amidst Macroeconomic Headwinds Steady Operational Performance Amidst Macroeconomic Headwinds

3 months ago - GlobeNewsWire

SOPHiA GENETICS to Host Investor Day on September 20, 2022, in New York City

BOSTON and LAUSANNE, Switzerland, Aug. 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today it will host its first-eve...

3 months ago - GlobeNewsWire

SOPHiA GENETICS to Participate in Canaccord Genuity 42nd Annual Growth Conference

BOSTON and LAUSANNE, Switzerland, July 29, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, announced today Chief Financial Officer, Ross Muken, will attend ...

4 months ago - GlobeNewsWire

SOPHiA GENETICS to Announce Financial Results for the Second Quarter of Fiscal 2022 on August 9, 2022

BOSTON and LAUSANNE, Switzerland, July 14, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for the sec...

4 months ago - GlobeNewsWire

SOPHiA GENETICS Publishes Results of 2022 Annual General Meeting

BOSTON and LAUSANNE, Switzerland , June 15, 2022 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH) ("the Company"), is pleased to announce the Annual General Meeting ("the Meeting") was held at the Comp...

5 months ago - PRNewsWire

SOPHiA GENETICS Publishes Environmental, Social and Governance Impact Summary

BOSTON and LAUSANNE, Switzerland , June 15, 2022 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH) ("the Company"), today announced that the Company has published its first Environmental, Social and Gov...

5 months ago - PRNewsWire

SOPHiA GENETICS Launches New Solution to Advance Chronic Lymphocytic Leukemia Care, in Collaboration with IDIBAPS

BOSTON and LAUSANNE, Switzerland , June 9, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), the Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) of Barcelona, and the Spanish Diagn...

5 months ago - PRNewsWire

SOPHiA GENETICS Provides an Update on its DEEP-Lung-IV Multimodal Clinical Study at ASCO 2022

Study leverages deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy and prognosis of patients with...

5 months ago - PRNewsWire

SOPHiA GENETICS Announces Three Poster Presentations and One Online Publication Accepted at the 2022 American Society...

BOSTON and LAUSANNE, Switzerland , June 1, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in data-driven medicine, today announced three abstracts accepted for poster presentation and one...

5 months ago - PRNewsWire

SOPHiA GENETICS Announces Nomination of Jean-Michel Cosséry to Board of Directors

BOSTON and LAUSANNE, Switzerland , May 5, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in data-driven medicine, today announced the nomination of Jean-Michel Cosséry to its Board of Dir...

6 months ago - PRNewsWire

SOPHiA GENETICS Hits Milestone of One Million Genomic Profiles Analyzed by the SOPHiA DDM™ Platform

BOSTON and LAUSANNE, Switzerland , April 26, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in data-driven medicine, has reached the milestone of one million genomic profiles analyzed by ...

7 months ago - PRNewsWire

SOPHiA GENETICS to Announce Financial Results for the First Quarter of Fiscal 2022 on May 10, 2022

BOSTON and LAUSANNE, Switzerland, April 13, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for the fi...

7 months ago - GlobeNewsWire

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2021 Financial Results

Revenues Grew 40% for the Fourth Quarter and 42% for Full Year 2021 2022 Guidance Reaffirmed

8 months ago - GlobeNewsWire

SOPHiA GENETICS and REALM IDx Sign Letter of Intent to Collaborate in Accelerating Cancer Research

The intended collaboration aims to help improve patient care by enhancing next-generation sequencing research for cancer care and expanding data sources for precision medicine. BOSTON, ALISO VIEJO, Calif.

8 months ago - PRNewsWire

SOPHiA GENETICS HRD Solution Adopted in Asia Pacific

BOSTON, LAUSANNE, Switzerland and TAIPEI CITY, Taiwan, March 9, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH) today announced that SOFIVA GENOMICS, which is one of the largest genetic testing comp...

8 months ago - PRNewsWire

SOPHiA GENETICS to Participate in Fireside Chat at Barclays Global Healthcare Conference

BOSTON and LAUSANNE, Switzerland, March 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, announced today Chief Executive Officer and Co-Founder Dr. Jurgi...

8 months ago - GlobeNewsWire